Like Team IMU, Team CHM is judged by the sp not by what's really important, the science. That's the way it is, low sp means the company is crap regardless of what's behind the scenes. IMU got hammered too despite being the star for Her-Vaxx and now CF33. The world had marked down almost all bio-tech juniors, not just the Hopper ones.
Hopper won't let this one fail, the science is too compelling. IMU can step in at any time. Like the banks did with Centro group after the GFC. Drive it down to 1c, take over, make billions a few years later. Thanks to stupid retail holders. Bought a massive stake a few years in CHK under similar circumstances, made a mozza later. Fear is a massive force and sometimes scares the crap out of people. Not proud to make money that way but if an opportunity like this is presented why not taking advantage of it.
GLTA
valuation thoughts, page-376
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
